A retrospective study conducted in Japan by Shiraki et al. [22] demonstrated that 95% and 71% of patients had positive values of AFP-L3 at 3 and 6 months before diagnosis of HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.